To evaluate the potential predictive effect of RFC2 on the sensitivity to immune checkpoint inhibitors, we analyzed the associations between RFC2 expression and TMB, tumor MSI, and MMR genes in LGG and other cancer types. This evidence concerns the gene MRC1 and cancer.